504 related articles for article (PubMed ID: 21362138)
21. CD44s adhesive function spontaneous and PMA-inducible CD44 cleavage are regulated at post-translational level in cells of melanocytic lineage.
Gasbarri A; Del Prete F; Girnita L; Martegani MP; Natali PG; Bartolazzi A
Melanoma Res; 2003 Aug; 13(4):325-37. PubMed ID: 12883358
[TBL] [Abstract][Full Text] [Related]
22. CD44 integrates signaling in normal stem cell, cancer stem cell and (pre)metastatic niches.
Williams K; Motiani K; Giridhar PV; Kasper S
Exp Biol Med (Maywood); 2013 Mar; 238(3):324-38. PubMed ID: 23598979
[TBL] [Abstract][Full Text] [Related]
23. Activation of Matrix Hyaluronan-Mediated CD44 Signaling, Epigenetic Regulation and Chemoresistance in Head and Neck Cancer Stem Cells.
Bourguignon LYW; Earle C; Shiina M
Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28837080
[TBL] [Abstract][Full Text] [Related]
24. Interplay between Podoplanin, CD44s and CD44v in Squamous Carcinoma Cells.
Montero-Montero L; Renart J; Ramírez A; Ramos C; Shamhood M; Jarcovsky R; Quintanilla M; Martín-Villar E
Cells; 2020 Sep; 9(10):. PubMed ID: 33003440
[TBL] [Abstract][Full Text] [Related]
25. CD44 and Tumor-Derived Extracellular Vesicles (TEVs). Possible Gateway to Cancer Metastasis.
Szatanek R; Baj-Krzyworzeka M
Int J Mol Sci; 2021 Feb; 22(3):. PubMed ID: 33540535
[TBL] [Abstract][Full Text] [Related]
26. Migration of highly aggressive melanoma cells on hyaluronic acid is associated with functional changes, increased turnover and shedding of CD44 receptors.
Goebeler M; Kaufmann D; Bröcker EB; Klein CE
J Cell Sci; 1996 Jul; 109 ( Pt 7)():1957-64. PubMed ID: 8832418
[TBL] [Abstract][Full Text] [Related]
27. The CD44 receptor of the mouse LB T-cell lymphoma: analysis of the isoform repertoire and ligand binding properties by reverse-transcriptase polymerase chain reaction and antisense oligonucleotides.
Wallach SB; Friedmann A; Naor D
Cancer Detect Prev; 2000; 24(1):33-45. PubMed ID: 10757121
[TBL] [Abstract][Full Text] [Related]
28. Differential expression of the human metastasis adhesion molecule CD44V in normal and carcinomatous stomach mucosa of Chinese subjects.
Harn HJ; Ho LI; Chang JY; Wu CW; Jiang SY; Lee HS; Lee WH
Cancer; 1995 Mar; 75(5):1065-71. PubMed ID: 7531611
[TBL] [Abstract][Full Text] [Related]
29. CD44: a cancer stem cell marker and therapeutic target in leukemia treatment.
Wu S; Tan Y; Li F; Han Y; Zhang S; Lin X
Front Immunol; 2024; 15():1354992. PubMed ID: 38736891
[TBL] [Abstract][Full Text] [Related]
30. CD44 loss in gastric stromal tumors as a prognostic marker.
Montgomery E; Abraham SC; Fisher C; Deasel MR; Amr SS; Sheikh SS; House M; Lilliemoe K; Choti M; Brock M; Ephron DT; Zahuruk M; Chadburn A
Am J Surg Pathol; 2004 Feb; 28(2):168-77. PubMed ID: 15043305
[TBL] [Abstract][Full Text] [Related]
31. Rheostatic signaling by CD44 and hyaluronan.
Puré E; Assoian RK
Cell Signal; 2009 May; 21(5):651-5. PubMed ID: 19174187
[TBL] [Abstract][Full Text] [Related]
32. Tumor-suppressive functions of 4-MU on breast cancer cells of different ER status: Regulation of hyaluronan/HAS2/CD44 and specific matrix effectors.
Karalis TT; Heldin P; Vynios DH; Neill T; Buraschi S; Iozzo RV; Karamanos NK; Skandalis SS
Matrix Biol; 2019 May; 78-79():118-138. PubMed ID: 29673760
[TBL] [Abstract][Full Text] [Related]
33. Expression of CD44 standard form and variant isoforms in non-small cell lung carcinomas.
Tran TA; Kallakury BV; Sheehan CE; Ross JS
Hum Pathol; 1997 Jul; 28(7):809-14. PubMed ID: 9224749
[TBL] [Abstract][Full Text] [Related]
34. Cytokines regulate the affinity of soluble CD44 for hyaluronan.
Cichy J; Puré E
FEBS Lett; 2004 Jan; 556(1-3):69-74. PubMed ID: 14706828
[TBL] [Abstract][Full Text] [Related]
35. The Role of CD44 and Cancer Stem Cells.
Wang L; Zuo X; Xie K; Wei D
Methods Mol Biol; 2018; 1692():31-42. PubMed ID: 28986884
[TBL] [Abstract][Full Text] [Related]
36. Hyaluronan delays human amniotic epithelial stem cell senescence by regulating CD44 isoform switch to activate AKT/mTOR signals.
Yu C; Yuan H; Xu Y; Luo Y; Wu ZH; Zhong JJ; Xiao JH
Biomed Pharmacother; 2024 Jan; 170():116100. PubMed ID: 38159379
[TBL] [Abstract][Full Text] [Related]
37. Evaluating the Efficiency of Hyaluronic Acid for Tumor Targeting via CD44.
Spadea A; Rios de la Rosa JM; Tirella A; Ashford MB; Williams KJ; Stratford IJ; Tirelli N; Mehibel M
Mol Pharm; 2019 Jun; 16(6):2481-2493. PubMed ID: 31013093
[TBL] [Abstract][Full Text] [Related]
38. The biology and role of CD44 in cancer progression: therapeutic implications.
Chen C; Zhao S; Karnad A; Freeman JW
J Hematol Oncol; 2018 May; 11(1):64. PubMed ID: 29747682
[TBL] [Abstract][Full Text] [Related]
39. Hyaluronan promotes signaling interaction between CD44 and the transforming growth factor beta receptor I in metastatic breast tumor cells.
Bourguignon LY; Singleton PA; Zhu H; Zhou B
J Biol Chem; 2002 Oct; 277(42):39703-12. PubMed ID: 12145287
[TBL] [Abstract][Full Text] [Related]
40. CD44 phosphorylation regulates melanoma cell and fibroblast migration on, but not attachment to, a hyaluronan substratum.
Peck D; Isacke CM
Curr Biol; 1996 Jul; 6(7):884-90. PubMed ID: 8805300
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
